Position in KRYS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$441,727
-$262,144 QoQ
Shares Held
1,710
-40.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Optimize Financial Inc holds $10,398,491 across 24 Biotechnology names. KRYS ranks #10 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KOD |
Kodiak Sciences Inc.
|
17,828 | $679,603 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
13,442 | $659,330 | |
| 3 | ELVN |
Enliven Therapeutics, Inc.
|
15,055 | $590,156 | |
| 4 | BCAX |
Bicara Therapeutics Inc.
|
23,996 | $477,280 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
2,730 | $461,424 | |
| 6 | SVRA |
Savara Inc
|
84,103 | $459,202 | |
| 7 | RAPP |
Rapport Therapeutics, Inc.
|
14,656 | $458,586 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,381 | $456,931 |
All Filings in KRYS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $441,727 | 1,710 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $703,871 | 2,855 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $496,931 | 2,815 | Shares | Sole | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||